Immunitybio Inc (IBRX)

Investing Cash Flow

-$107.47M

Quarterly · Period ending: · USD

IBRX logo

IBRX Investing Cash Flow

Latest reported-$107.47M
IBRX Quarterly Cash from Investing (-$2.00K → -$107.47M)
High-resolution chart · PNG

IBRX investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-107,469,000
-31,650,000
43,573,000
-181,361,000
-16,142,000
4,129,000
9,834,000
65,032,000
-51,490,000
-35,622,000
2,249,000
-15,631,000
-8,604,000
-8,484,000
-18,894,000
-1,168,000
116,672,000
-69,313,000
-137,802,000
10,582,000
10,489,000
31,845,000
7,545,000
-56,625,000
15,274,000
13,994,000
12,163,000
17,374,000
11,378,000
-19,459,000
15,914,000
16,874,000
21,393,000
2,920,000
19,734,000
6,961,000
56,819,000
16,038,000
-8,464,000
6,855,000
-10,151,000
-101,912,000
-171,979,000
-672,000
-666,000
-1,907,000
-48,000
-234,000
-15,000
-2,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.